The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks

Authors
Category Systematic review
JournalHypertension research : official journal of the Japanese Society of Hypertension
Year 2024
This article has no abstract
Epistemonikos ID: 1cda196b23afceb2fd8ce080dc324411105f0fae
First added on: Jul 02, 2024